Capecitabine and vinorelbine as first-line treatment in elderly patients (≥65 years) with metastatic breast cancer: A phase II trial (SAKK 25/99)

Oncology

Volumn 73, Issue 3-4, 2008, Pages 228-237

  Hess, D ^a   Koberle D ^a   Thurlimann B ^a   Pagani, O ^b   Schonenberger A ^c   Mattmann, S ^d   Rochlitz, C ^e   Rauch, D ^f   Schuller, J C ^g   Ballabeni, P ^g   Ribi, K ^g  

^a Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

^b OSPEDALE SAN GIOVANNI   (Switzerland)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

^d LUZERNER KANTONSSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Spital Thun STS AG   (Switzerland)

^g SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

Advanced disease; Breast cancer; Capecitabine; Elderly patients; Phase II trial; Vinorelbine

Indexed keywords

ANTIEMETIC AGENT; CAPECITABINE; NAVELBINE;

ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BOLUS INJECTION; BONE METASTASIS; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ELDERLY CARE; FATIGUE; GERIATRIC PATIENT; HAND FOOT SYNDROME; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MUCOSAL DISEASE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN TOXICITY; STOMATITIS; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT FAILURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WELLBEING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BREAST NEOPLASMS; COHORT STUDIES; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MAXIMUM TOLERATED DOSE; SKIN NEOPLASMS; TREATMENT OUTCOME; VINBLASTINE;

EID: 43049090899     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127414     Document Type: Article

References (23)

1. Mandelblatt J: Treating breast cancer: The age old dilemma of old age. J Clin Oncol 2006;24:4369-4370.
2. Enger S, Thwin S, Buist D, et al: Breast cancer treatment of older women in integrated health care settings. J Clin Oncol 2006;24:4377-4383.
3. Muss HB, Woolf S, Berry D, et al: Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293:1073-1081.
4. Sawada N, Fujimoto-Ouchi K, Ishikawa T, et al: Antitumor activity of combination therapy with capecitabine plus vinorelbine, and capecitabine plus gemcitabine in human xenograft models (abstract 5388). Proc Am Assoc Cancer Res 2002;43:1068.
5. Hess D, Thürlimann B, Pagani O, et al: Capecitabine and vinorelbine in elderly patients (≥ 65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99). Ann Oncol 2004;15:1760-1765.
6. Priestmann TJ, Baum M: Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1976;i:899-900.
7. Hürny C, Bernhard J, Coates A, et al: Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care 1996;34:234-248.
8. Hürny C, Bernhard J, Bacchi M, et al: The perceived adjustment to chronic illness scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. SAKK and IBCSG. Support Care Cancer 1993;1:200-208.
9. Bernhard J, Hürny C, Maibach R, et al: Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1999;10:775-782.
10. Kummel S, Elling D, Jeschke S, et al: Chemotherapy treatment options for elderly women with breast cancer. Anticancer Res 2006;26:1673-1676.
11. Dieras V, Extra JM, Bellissant E, et al: Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method. J Clin Oncol 1996;14:3097-3104.
12. NolèF, de Braud F, Aapro MS, et al: Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden. Ann Oncol 1997;8:865-870.
13. Berruti A, Sperone P, Bottini A, et al: Phase I study of vinorelbine with protracted fluorouracil infusion as second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines. J Clin Oncol 2000;18:3370-3377.
14. Pruemer J: Prevalence, causes and impact of cancer-associated thrombosis. Am J Health Syst Pharm 2005;62(22 suppl 5):S4-S6.
15. Chew HK, Wun T, Harvey DJ, et al: Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 2007;25:70-76.
16. Bajetta E, Procopio G, Celio L, et al: Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women. J Clin Oncol 2005;23:2155-2161.
17. Welt A, von Minckwitz G, Oberhoff C, et al: Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer. Ann Oncol 2005;16:64-69.
18. NolèF, Catania C, Sanna G, et al: Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer. Ann Oncol 2006;17:322-329.
19. NolèF, Catania C, Munzone E, et al: Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer. Clin Breast Cancer 2006;6:518-524.
20. Lorusso V, Crucitta E, Silvestris N, et al: A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer. Clin Breast Cancer 2003;4:138-141.
21. Ahn JH, Kim SB, Kim TW, et al: Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane. J Korean Med Sci 2004;19:547-553.
22. Iodice G, D'Aiuto G, Comella P, et al: Dose-escalated vinorelbine-capecitabine in elderly metastatic breast cancer patients. A SICOG phase II study (abstract 155P). Ann Oncol 2006;17(suppl 9):ix73.
23. Köhler U, Luhn B, Kleine-Tebbe A, et al: Capecitabine and vinorelbine in elderly patients with metastatic breast cancer as 1st line treatment: a prospective multicenter phase II study of the NOGGO breast cancer study group (abstract 6089). Breast Cancer Res Treat 2006;100:S285.